Legacy Edge Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Legacy Edge Advisors's PFE Position: Q3 2026 in Review
Legacy Edge Advisors reduced its Pfizer (PFE) stake by 8.8% in Q3 2026, selling an estimated $28.2K and leaving 10,964 shares worth $313K. The position accounts for 0.03% of the portfolio, ranked #197.
Legacy Edge Advisors first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. The position peaked at $341K in Q3 2024. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Legacy Edge Advisors held 10,964 shares of Pfizer worth $313K as of Q3 2026.
- Legacy Edge Advisors sold 1,061 Pfizer shares in Q3 2026, an estimated $28.2K.
- Pfizer made up 0.03% of Legacy Edge Advisors's portfolio in Q3 2026, its #197 holding.
- Legacy Edge Advisors first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
- Legacy Edge Advisors's Pfizer position peaked at $341K in Q3 2024.
- 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Legacy Edge Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.